Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies
Barry A SchechterCornea and Cataract Service, Florida Eye Microsurgical Institute, Boynton Beach, FL, USAAbstract: Topical ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat postoperative inflammation and pain following cataract surgery and for treatment and prophyla...
Enregistré dans:
Auteur principal: | Schechter BA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c99162c1e0de4c70bfd03d76bcb45647 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
par: Palacio C, et autres
Publié: (2016) -
Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
par: Sheppard JD
Publié: (2016) -
Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery
par: Kim T, et autres
Publié: (2018) -
A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
par: Hosseini K, et autres
Publié: (2016) -
Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
par: Brooks CC, et autres
Publié: (2020)